Adaptable framework for cost-analyses in radiotherapy: Application to the cost of proton versus photon therapy for lung cancer in The Netherlands
An adaptable framework for probabilistic cost-analyses was developed. Results highlight cost disparities between PrT and PhT and serves to inform future cost-effectiveness analyses. Scenarios reveal potential for clinical experience and increased capacity to narrow differences. Parallel base-case analyses highlight cost disparities arising when utilising generic vs centre-specific inputs, and potential outcome differences between centres.
Authors
- Manuela A. Joore (ORCID: https://orcid.org/0000-0002-5649-6768)
- Djoya Hattu (ORCID: https://orcid.org/0000-0003-1417-2877)
- Weaver Robert A.
- Maria Jacobs (ORCID: https://orcid.org/0000-0001-8832-2378)
- Bram Ramaekers (ORCID: https://orcid.org/0000-0001-5785-9228)
- О. Savchuk (ORCID: https://orcid.org/0000-0003-3621-6981)
- Boy Vluggen
- Loon J van
- De Ruysscher D
Institutions
- Tilburg University (NL)
- Maastricht University Medical Centre (NL)
- Maastro Clinic (NL)
Publication Details
- Journal
- Radiotherapy and Oncology
- Published
- 2025-03-08
- DOI
- https://doi.org/10.1016/j.radonc.2025.110832
- Citations
- 1
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Government of the United Kingdom
- European Commission
- ZonMw
- HORIZON EUROPE Framework Programme
- Staatssekretariat für Bildung, Forschung und Innovation